$LQDA

JEFFS ROGER sold $1.5M of LQDA (indirect holdings)

JEFFS ROGER (Chief Executive Officer) sold 25,000 indirectly-held shares of Liquidia Corp (LQDA) at $61.13 ($1.53M total) on 2026-05-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JEFFS ROGER
Published May 26, 2026, 10:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 10:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralMed
01

Why it matters

The disclosure can influence short-term sentiment and options/flow positioning, but the presence of a 10b5-1 plan generally lowers the probability that the sale signals new adverse fundamentals.

02

Market read

A $1.53M CEO open-market sale under a 10b5-1 plan is more of a sentiment datapoint than a fundamental catalyst for LQDA.

03

What to watch

Check whether there are multiple consecutive insider sales, changes in total insider ownership, or concurrent news (trial/financing) that would make the sale more informative.

Relevance 7/10Timing: Potential short-term sentiment effect around the filing date (2026-05-26) and subsequent tape reaction.

Background

The article is an SEC Form 4 insider transaction disclosure for Liquidia Corp, filed on 2026-05-26, covering a sale executed 2026-05-21.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia CEO Jeffs Roger sold 25,000 shares in an open-market transaction worth about $1.53M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any reaction may fade unless accompanied by other negative company-specific news.

Evidence & confidence

The filing is an SEC Form 4 insider sale with explicit 10b5-1 pre-arrangement, which typically dampens interpretability as a new bearish thesis.

Market effects

Minimal sector read-through; this is company-specific insider liquidity rather than an operational/regulatory update.

No clear regional impact indicated by the filing alone.

No global relevance beyond the issuer’s own trading sentiment.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine diversification/compensation rather than negative expectations.

Key entities

  • Liquidia Corp

    Subject of the Form 4 insider transaction; CEO sold 25,000 shares open-market under a 10b5-1 plan.

  • Jeffs Roger

    Chief Executive Officer and director who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LQDAHighAI 8/10

Why is Liquidia stock cratering today?

Liquidia Corporation's stock fell 48.3% to $36.55 after a court ruled it infringed two claims of United Therapeutics' patent, impacting its YUTREPIA drug. The company plans to remove a key indication and may face further restrictions. United Therapeutics' stock rose. The broader market gained slightly.